Erythropoiesis-stimulating agents (ESAs), from chemotherapy-induced anemia to any cancer-related anemia?
-
Published:2010-04
Issue:4
Volume:21
Page:905-906
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Venturino A.,Colloca G.
Subject
Oncology,Hematology
Reference15 articles.
1. Modeling of treatment response to erythropoiesis-stimulating agents as a function of centre- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study;Aapro;Ann Oncol,2009
2. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients;Ludwig;Eur J Cancer,2004
3. The background and methodology of the Anaemia Cancer Treatment (A.C.T.) study: a global retrospective study of practice patterns and outcomes in the management of anaemia in cancer patients and their congruence with evidence-based guidelines;Aapro;Support Care Cancer,2008
4. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?;Zarychanski;CMAJ,2008
5. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications;Theurl;Blood,2009